|
|
![]() |
![]() ![]() |
![]() |
|
||
![]() |
![]() |
Re: where it goesI'm not about the next few weeks, acad is building a fanchise in rare diseases which has a lot of potential and is quite rare. ( pardon the pun). Profitability and a maturing pipeline in a small biotech is in itself quite rare. This an attractive acquisition. |
![]() ![]() ![]() ![]() |
return to message board, top of board |